Addictovigilance contribution during COVID-19 epidemic and lockdown in France
Maryse Lapeyre‐Mestre(Université Fédérale de Toulouse Midi-Pyrénées), Juliana Tournebize
Cited by 72
Related Papers
Early Detection of Prescription Drug Abuse Using Doctor Shopping Monitoring From Claims Databases: Illustration From the Experience of the French Addictovigilance Network
|Frontiers in Psychiatry|2021|20
Patterns of ketamine use among people with substance use disorder in France: Multisource analysis of the data from the French Addictovigilance Network
|Fundamental and Clinical Pharmacology|2024|13
Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022
|CNS Drugs|2024|8
French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change
|European Journal of Public Health|2023|6